Employees

  • Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Rule 5635(c)(4)

    Rigel Pharmaceuticals has granted stock options and restricted stock units to 11 non-executive employees under its Inducement Plan. This initiative, approved by the Compensation Committee, aims to attract and retain talent by aligning employee incentives with company growth. Awards vest over four years, with a one-year cliff. This equity-based compensation strategy is common in the biotech sector to foster employee commitment and shareholder value.

    2026年2月13日